J.P. Morgan Maintains Overweight Rating on IMAX Corporation
J.P. Morgan has reaffirmed its 'Overweight' rating for IMAX Corporation, maintaining a positive outlook on the company's stock.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
J.P. Morgan has reaffirmed its 'Overweight' rating for IMAX Corporation, maintaining a positive outlook on the company's stock.
Wedbush analyst Alicia Reese maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $54 to $60.
Five stocks have been added to the Zacks Rank #1 (Strong Buy) list, driven by increasing earnings estimates over the last 60 days. The stocks span energy, manufacturing, entertainment, insurance, and retail sectors, with earnings estimate increases ranging from 10% to 15.4%. The market is focused on upcoming CPI and PPI inflation reports and the start of Q3 earnings season.